Longitudinal analysis shows how microbiome changes might influence responses to immune checkpoint blockade
Nat Med
.
2024 Mar;30(3):644-645.
doi: 10.1038/s41591-024-02830-0.
PMID:
38388842
DOI:
10.1038/s41591-024-02830-0
No abstract available
MeSH terms
Humans
Immune Checkpoint Inhibitors / therapeutic use
Immunotherapy
Microbiota*
Neoplasms*
Substances
Immune Checkpoint Inhibitors